Wright Medical — Tornier — Investor Presentation (January 2013)
26 slides from Wright Medical's investor presentation, Jan 7, 2013
Slide 1: David Mowry, Interim President and CEO
January 7, 2012 David Mowry, Interim President and CEO Specialists SERVING Specialists Exhibit 99.2
Slide 2: Forward-Looking Statements
Forward-Looking Statements Statements contained in this presentation that relate to future, not past, events are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on current expectations of future events and often can be ident
Slide 3: Non-GAAP Financial Measures
Non-GAAP Financial Measures Tornier uses certain non-GAAP financial measures in this presentation, such as constant currency. Tornier uses non-GAAP financial measures as supplemental measures of performance and believes these measures provide useful information to investors in evaluating Tornier’s o
Slide 4: Global Medical Device Company, Focusing on Surgeons Treating Extremities Injuries and Disorders
Global Medical Device Company, Focusing on Surgeons Treating Extremities Injuries and Disorders Specialists SERVING Specialists EXTREMITIES
Slide 5: The Tornier Story: Positioning for Future Growth
The Tornier Story: Positioning for Future Growth BROADEST PRODUCT PORTFOLIO HIGH GROWTH MARKET SCALE FOR EFFICIENT SALES Extremities Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science & Education Robust Drivers Assure Growth $6.5B 7-9% CAGR (’12 – ’17) Targe
Slide 6: Attractive Market for Extremities
Attractive Market for Extremities BROADEST PRODUCT PORTFOLIO SCALE FOR EFFICIENT SALES HIGH GROWTH MARKET Extremities Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science Education Target High-Volume Extremities Specialists EXECUTION FOCUS FOR 2013 Robust Driv
Slide 7: Large and Growing Global Extremities Market
Large and Growing Global Extremities Market 8-9% CAGR UPPER EXTREMITES 7-8% CAGR SPORTS MEDICINE & BIOLOGICS 7-8% CAGR LOWER EXTREMITIES $2.7B ~ $4.0B $2.1B ~ $3.0B $1.7B ~ $2.5B Total Extremities Market Is $6.5B with 7-9% CAGR 2012 2017 2012 2017 2012 2017
Slide 8: Robust Extremities Market Drivers Provide Opportunity for Future Growth and Differentiation
Robust Extremities Market Drivers Provide Opportunity for Future Growth and Differentiation Active, Younger Patient Population Expanding Knowledge of Treatment Options Early Stages of Device Innovation Opportunity for Material and Design Improvements TECHNOLOGY PATIENTS OUTCOMES Upside for Continued
Slide 9: 2012 Actions Focused on Capturing Opportunities
2012 Actions Focused on Capturing Opportunities ACTIONS OPPORTUNITY 1 2 3 ACTIONS OPPORTUNITY Specific Press-fit Shoulder Broaden Lower Extremities Offering US SALES CHANNEL EXECUTION OVERHEAD / EXPENSE REDUCTION Access to Foot & Ankle Sales Channel New Sales Management Organization Developed 2013 P
Slide 10: OrthoHelix Acquisition: Complementary Capabilities
OrthoHelix Acquisition: Complementary Capabilities PRODUCTS Broad Shoulder Portfolio Elbow Arthroplasty Strong Ankle Arthroplasty Sports Medicine & Biologics Foot & Ankle Fixation Comprehensive Upper & Lower Extremities Portfolio with Minimal Overlap GEOGRAPHY US Europe Emerging Markets US Only Chan
Slide 11: Filling Out Our Extremities Product Portfolio
Filling Out Our Extremities Product Portfolio SCALE FOR EFFICIENT SALES HIGH GROWTH MARKET BROADEST PRODUCT PORTFOLIO Target High-Volume Extremities Specialists Robust Drivers Assure Growth Extremities $6.5B EXECUTION FOCUS FOR 2013 BROADEST PRODUCT PORTFOLIO Upper Extremities Lower Extremities Biol
Slide 12: Portfolio Strategy Leverages Strong Arthroplasty Position
Portfolio Strategy Leverages Strong Arthroplasty Position #2 Top 5 #1 JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE $1.2B $6.5B CALL POINT FOCUS JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE SHOULDER HAND, WRIST AND ELBOW FOOT AND ANKLE PROCEDURES LEVERAGE Strength of Products
Slide 13: Most Comprehensive Extremities Product Portfolio
13 12 10 2 3 35 9 Most Comprehensive Extremities Product Portfolio 4 JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE CALL POINT FOCUS 88 Distinct Extremities Products JOINT REPLACEMENTS BONE REPAIR BIOLOGICS SPORTS MEDICINE SHOULDER HAND, WRIST AND ELBOW FOOT AND ANKLE PROCEDURES
Slide 14: Filling Out Portfolio with High-Impact New Products
Filling Out Portfolio with High-Impact New Products UPPER EXTREMITIES LOWER EXTREMITIES January ‘13 UPPER EXTREMITIES Shoulder Arthroplasty % of Addressed Procedures ADDED Ascend Flex Press-Fit Reverse Shoulder (Revision Friendly) LOWER EXTREMITIES Foot and Ankle Procedures % of Addressable Procedur
Slide 15: Tornier Shoulder Portfolio: Building a Continuum of Care
Anatomic Reverse Convertible Tornier Shoulder Portfolio: Building a Continuum of Care Varying Treatment Anchors Fracture Resurfacing Stemless Revision CTA Glenoid Conservative to More Aggressive Treatments PyC Ascend Flex Options
Slide 16: The “Go-To” Company for the Specialist
The “Go-To” Company for the Specialist RESPECTED FOR SCIENTIFIC RIGOR CLINICAL DATA DRIVEN STRATEGY Aequalis Shoulder Registry Simpliciti Shoulder US IDE Study Salto-Talaris Total Ankle Data Set Pyrolytic Carbon Material & Application Biologic Augmentation Synthetic Growth Factors Significant Invest
Slide 17: Efficient, Targeted Sales Distribution
Efficient, Targeted Sales Distribution BROADEST PRODUCT PORTFOLIO HIGH GROWTH MARKET SCALE FOR EFFICIENT SALES Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science Education Robust Drivers Assure Growth Extremities $6.5B 7-9% CAGR (’202 – 2017) EXECUTION FOCUS
Slide 18: US: Planning for Focused Upper and Lower Sales Distribution
US: Planning for Focused Upper and Lower Sales Distribution Scale Drives Flexibility CHANNEL FOCUS MIRRORS CUSTOMER SPECIALIZATION Upper Extremities Lower Extremities Sales Force: Surgeon Specialists: Shoulder, Elbow, Wrist & Hand Foot and Ankle Complete Offering / Procedure Coverage Product Pull-th
Slide 19: International: Addressing Mature and Underpenetrated Markets
International: Addressing Mature and Underpenetrated Markets OUS Launch of OrthoHelix Products in 2H ‘13 MATURE MARKETS – Focused Extremities Channels – Japan Converted to Direct 2Q12 – Belgium Converted to Direct in 3Q12 – Canada Conversion Planned for 1H13 UNDER PENETRATED MARKETS – Underpenetrate
Slide 20: The Outlook for 2013
The Outlook for 2013 BROADEST PRODUCT PORTFOLIO SCALE FOR EFFICIENT SALES HIGH GROWTH MARKET Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science Education Target High-Volume Extremities Specialists Upper Extremities Lower Extremities Robust Drivers Assure Gro
Slide 21: Energized, Execution-Focused Leadership Team
POSITION EXPERIENCE Energized, Execution-Focused Leadership Team POSITION EXPERIENCE Dave Mowry Interim President & CEO Shawn McCormick CFO Terry Rich SVP US Commercial Ops David Andersen VP Global Marketing Robert Ball VP Global R & D Stéphan Epinette VP International Commercial Ops Kevin Klemz VP,
Slide 22: Positioning the Company for Future Growth
Positioning the Company for Future Growth TECHNOLOGY LEADER DRIVE REVENUE DRIVE REVENUE INCREASE GROWTH RATE Continue to Innovate Across Portfolio 10 – 12 New Products Per Year Increase the Focus of Our Sales Channels Balanced Global Extremities Growth Direct in Mature Markets; Expand in Emerging Ma
Slide 23: 2013 – We Will Focus on a Vital Few Initiatives
2013 – We Will Focus on a Vital Few Initiatives 1 2 3 US Sales Channel Alignment OrthoHelix Integration New Product Launches
Slide 24: Positioned for Growth: Revenue
Positioned for Growth: Revenue HISTORY GEOGRAPHY $75.8-78.8M* US ~56% OUS ~44% * Expected 2012 revenue as reiterated in press release on January 7, 2013 HISTORY GEOGRAPHY $201M $227M $261M $274 - 277M* 2009 2010 2011 Expected 2012 $274 - $277M Expected 2012*
Slide 25: Summary
Summary BROADEST PRODUCT PORTFOLIO HIGH GROWTH MARKET Extremities SCALE FOR EFFICIENT SALES BROADEST PRODUCT PORTFOLIO Upper Extremities Lower Extremities Biologics/ Sports Medicine Leader in Innovation, Science & Education HIGH GROWTH MARKET Robust Drivers Assure Growth $6.5B 7-9% CAGR (’12 – ’17)
Slide 26: Specialists SERVING Specialists
Specialists SERVING Specialists